Optimal supportive care that includes patient education and anticipatory management of common adverse effects (AE) can improve adherence to treatment protocols and result in better response rates in patients receiving selinexor for relapsed/refractory multiple myeloma (MM). These findings were demonstrated in an adverse effect (AE) management protocol presented during the Oncology Nursing Society (ONS) Bridge,…
Although psychological distress was not improved, this tailored intervention addressed other potential gaps in care needs of patients with gynecologic cancers undergoing RT.
Key recommendations from the Oncology Nursing Society clinical practice guidelines are presented.
Planned provision of patient assistance was key in this program developed to reduce the number of falls and fall-related injuries in hospitalized patients with cancer.
Odds of developing ICI colitis significantly reduced with vitamin D use in patients with melanoma.
As part of our 10-year celebration, the editors of ONA look at a subspecialty collaboration that can enhance palliative care and expand the multidisciplinary cancer care team.
Researchers aimed to determine whether the addition of radiotherapy was associated with a risk for adverse events among patients treated with ICIs.
The FDA has approved a new ready-to-dilute liquid formulation of Akynzeo® injection (fosnetupitant/palonosetron; Helsinn) for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy, in combination with dexamethasone in adults.
[Breast Cancer: Targets and Therapy] Nanosomal docetaxel lipid suspension was developed to minimize toxicity issues associated with conventional docetaxel. The efficacy and safety of NDLS-based chemotherapy in breast cancer was evaluated in this retrospective study.
Using remote communications technology, a major cancer center was able to manage symptoms in high-risk patients initiating treatment at a regional location.
